SCHEMBL19082356

SCHEMBL19082356

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6sc7c(ccc8c7sc7ccc9ccccc9c78)c6c5)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
MCL1 Q07820 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
CA12 O43570 4/20 0.34
CA1 P00915 4/20 0.34
CA2 P00918 4/20 0.34
CA9 Q16790 4/20 0.34
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
NQO2 P16083 2/20 0.33
CYP1A2 P05177 1/20 0.33
NQO1 P15559 1/20 0.33
S1PR4 O95977 3/20 0.33
S1PR5 Q9H228 3/20 0.33
F9 P00740 1/20 0.33
SOS1 Q07889 1/20 0.32
PRKDC P78527 2/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
EDNRB P24530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082103 0.94 ALOX5 (0.39) ALOX5MCL1ACMSDCA12CA1
SCHEMBL19082357 0.93 ALOX5 (0.39) ALOX5MCL1ACMSDCA12CA1
SCHEMBL19082351 0.93 ALOX5 (0.38) ALOX5MCL1ACMSDCA12CA1
SCHEMBL19082321 0.92 CYP1A1 (0.35) ALOX5CYP1A1CYP1B1NQO2CYP1A2
SCHEMBL17943989 0.91 ALOX5 (0.43) ALOX5MCL1ACMSDCA12CA1
SCHEMBL17945727 0.91 ALOX5 (0.49) ALOX5MCL1ACMSDCA12CA1
SCHEMBL24341502 0.91 ALOX5 (0.41) ALOX5MCL1ACMSDCA12CA1
SCHEMBL19082373 0.91 ALOX5 (0.36) ALOX5CA12CA1CA2CA9
SCHEMBL17944650 0.90 ALOX5 (0.43) ALOX5MCL1ACMSDCA12CA1
SCHEMBL17944939 0.90 MCL1 (0.38) ALOX5MCL1ACMSDCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885MCL1 1139/4885ACMSD 1586/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885MCL1 1139/4885ACMSD 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.